We are live on ! Find out more
PCM

Patient Capital Management Portfolio holdings

AUM $2.74B
1-Year Est. Return 43.59%
This Fund
S&P 500
This Quarter Est. Return
+10.92%
1 Year Est. Return
+43.59%
3 Year Est. Return
+124.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.17B
AUM Growth
+$131M
Cap. Flow
-$24.7M
Cap. Flow %
-1.14%
Top 10 Hldgs %
45.36%
Holding
43
New
2
Increased
15
Reduced
23
Closed
–

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$29.7M
2
KOS icon
Kosmos Energy
KOS
+$29.3M
3
BIIB icon
Biogen
BIIB
+$26.7M
4
SDRL icon
Seadrill
SDRL
+$25.2M
5
RPRX icon
Royalty Pharma
RPRX
+$22.1M

Top Sells

Rank Stock Value
1
TNL icon
Travel + Leisure Co
TNL
+$38.9M
2
EXPE icon
Expedia Group
EXPE
+$35.3M
3
FISV
Fiserv Inc
FISV
+$25.1M
4
UAL icon
United Airlines
UAL
+$23.7M
5
SOFI icon
SoFi Technologies
SOFI
+$20.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 27.73%
2 Financials 16.69%
3 Communication Services 14.9%
4 Healthcare 12.55%
5 Industrials 11.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CROX icon
26
Crocs
CROX
$6.61B
$48.8M 2.25%
445,227
+64,258
+17% +$7.48M
MAT icon
27
Mattel
MAT
$4.22B
$44.9M 2.07%
2,532,472
-4,173
-0.2% -$78.9K
GOOS
28
Canada Goose Holdings
GOOS
$856M
$38.7M 1.78%
3,854,520
+128,133
+3% +$1.31M
PTON icon
29
Peloton Interactive
PTON
$2.39B
$33.2M 1.53%
3,817,374
-1,237,958
-24% -$9.65M
FBTC icon
30
Fidelity Wise Origin Bitcoin Fund
FBTC
$12.1B
$24.9M 1.15%
305,603
+208,752
+216% +$15.1M
EXE
31
Expand Energy Corp
EXE
$21.7B
$23.6M 1.09%
236,911
+227
+0.1% +$21K
PGEN icon
32
Precigen
PGEN
$2.54B
$20M 0.92%
17,881,246
-56,448
-0.3% -$48.1K
JPM icon
33
JPMorgan Chase
JPM
$950B
$7.04M 0.33%
29,386
– –
TNL icon
34
Travel + Leisure Co
TNL
$4.67B
$5.88M 0.27%
116,599
-767,534
-87% -$38.9M
EVRI
35
DELISTED
Everi Holdings
EVRI
$4.06M 0.19%
300,310
-62,310
-17% -$833K
JD icon
36
JD.com
JD
$44.4B
$3.47M 0.16%
+100,000
New +$3.87M
WAL icon
37
Western Alliance Bancorporation
WAL
$8.9B
$2.36M 0.11%
28,282
-207,210
-88% -$18.2M
TEVA icon
38
Teva Pharmaceuticals
TEVA
$40.9B
$2.2M 0.1%
100,000
– –
FISV
39
Fiserv Inc
FISV
$27.5B
$2.06M 0.1%
10,042
-122,828
-92% -$25.1M
SPY icon
40
State Street SPDR S&P 500 ETF Trust
SPY
$822B
$2.03M 0.09%
3,463
+1,977
+133% +$1.16M
LEN.B icon
41
Lennar Class B
LEN.B
$20.5B
$1.65M 0.08%
13,150
– –
APA icon
42
APA Corp
APA
$13.3B
$1.15M 0.05%
+50,000
New +$1.17M
BRLT icon
43
Brilliant Earth
BRLT
$20.5M
$210K 0.01%
100,000
-141,445
-59% -$260K
1
2

Similar funds

CIAS
CBIZ Investment Advisory Services Independence, Ohio $2.74B AUM 14.19% 1-Year Est. Return
LMIM
Lockheed Martin Investment Management Bethesda, Maryland $2.73B AUM 28.24% 1-Year Est. Return
GC
Giverny Capital Montreal, Quebec, Canada $2.73B AUM 14.09% 1-Year Est. Return
CC
Cartenna Capital Stamford, Connecticut $2.74B AUM 44.46% 1-Year Est. Return
PA
Profund Advisors Bethesda, Maryland $2.72B AUM 47.27% 1-Year Est. Return
XL
XN LP New York $2.72B AUM 46.67% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

Patient Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Patient Capital Management held 43 positions worth $2.17B, up 6.4% from $2.04B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 4.7%. Patient Capital Management opened 2 new positions and made no exits, leaving the 43-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 28% of assets, down from 31% a quarter earlier, followed by Financials and Communication Services.

  • Patient Capital Management's largest Q4 2024 buy was JD.com: 100,000 shares worth $3.47M.
  • Patient Capital Management added most to CVS Health in Q4 2024, an estimated $29.7M increase.
  • Patient Capital Management's biggest Q4 2024 reduction was Travel + Leisure Co, cutting an estimated $38.9M.
  • Patient Capital Management's ten largest holdings make up 45% of its $2.17B portfolio in Q4 2024.
  • Patient Capital Management opened 2 new positions and closed 0 in Q4 2024.
  • Patient Capital Management's portfolio value rose 6.4% quarter-over-quarter to $2.17B.

Based on Patient Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.